These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 10604231

  • 1. Phage therapy: past history and future prospects.
    Carlton RM.
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231
    [Abstract] [Full Text] [Related]

  • 2. Bacteriophage therapy in children: facts and prospects.
    Fortuna W, Miedzybrodzki R, Weber-Dabrowska B, Górski A.
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [Abstract] [Full Text] [Related]

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 4. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
    Vinodkumar CS, Neelagund YF, Kalsurmath S.
    J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
    [Abstract] [Full Text] [Related]

  • 5. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM, Ritter K, Horz HP.
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [Abstract] [Full Text] [Related]

  • 6. [New perspectives of the phage therapy].
    Eyer L, Pantůcek R, Růzicková V, Doskar J.
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
    [Abstract] [Full Text] [Related]

  • 7. [Bacteriophages as antibacterial agents].
    Shasha SM, Sharon N, Inbar M.
    Harefuah; 2004 Feb; 143(2):121-5, 166. PubMed ID: 15143702
    [Abstract] [Full Text] [Related]

  • 8. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M, Adamia R.
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [Abstract] [Full Text] [Related]

  • 9. Phage therapy: a reappraisal of bacteriophages as antibiotics.
    Inal JM.
    Arch Immunol Ther Exp (Warsz); 2003 Dec; 51(4):237-44. PubMed ID: 12956433
    [Abstract] [Full Text] [Related]

  • 10. [Bacteria-killing viruses, Stalinists and "superbugs"].
    Olsen I, Handal T, Løkken P.
    Tidsskr Nor Laegeforen; 2001 Nov 10; 121(27):3197-200. PubMed ID: 11876146
    [Abstract] [Full Text] [Related]

  • 11. Is phage therapy acceptable in the immunocompromised host?
    Borysowski J, Górski A.
    Int J Infect Dis; 2008 Sep 10; 12(5):466-71. PubMed ID: 18400541
    [Abstract] [Full Text] [Related]

  • 12. The perspectives of the application of phage therapy in chronic bacterial prostatitis.
    Letkiewicz S, Międzybrodzki R, Kłak M, Jończyk E, Weber-Dąbrowska B, Górski A.
    FEMS Immunol Med Microbiol; 2010 Nov 10; 60(2):99-112. PubMed ID: 20698884
    [Abstract] [Full Text] [Related]

  • 13. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
    Burrowes B, Harper DR, Anderson J, McConville M, Enright MC.
    Expert Rev Anti Infect Ther; 2011 Sep 10; 9(9):775-85. PubMed ID: 21905786
    [Abstract] [Full Text] [Related]

  • 14. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
    Ahmad SI.
    Med Hypotheses; 2002 Apr 10; 58(4):327-31. PubMed ID: 12027527
    [Abstract] [Full Text] [Related]

  • 15. [Phagotherapy in terms of bacteriophage genetics: hopes, perspectives, safety, limitations].
    Krylov VN.
    Genetika; 2001 Jul 10; 37(7):869-87. PubMed ID: 11558226
    [Abstract] [Full Text] [Related]

  • 16. Bacteriophage therapy: an alternative to conventional antibiotics.
    Mathur MD, Vidhani S, Mehndiratta PL.
    J Assoc Physicians India; 2003 Jun 10; 51():593-6. PubMed ID: 15266928
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Long-circulating bacteriophage as antibacterial agents.
    Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, Adhya S.
    Proc Natl Acad Sci U S A; 1996 Apr 16; 93(8):3188-92. PubMed ID: 8622911
    [Abstract] [Full Text] [Related]

  • 19. Characterization of wild lambdoid bacteriophages: detection of a wide distribution of phage immunity groups and identification of a nus-dependent, nonlambdoid phage group.
    Kameyama L, Fernández L, Calderón J, Ortiz-Rojas A, Patterson TA.
    Virology; 1999 Oct 10; 263(1):100-11. PubMed ID: 10544086
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.